The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Top Cited Papers
Open Access
- 18 April 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 486 (7403), 346-352
- https://doi.org/10.1038/nature10983
Abstract
The elucidation of breast cancer subgroups and their molecular drivers requires integrated views of the genome and transcriptome from representative numbers of patients. We present an integrated analysis of copy number and gene expression in a discovery and validation set of 997 and 995 primary breast tumours, respectively, with long-term clinical follow-up. Inherited variants (copy number variants and single nucleotide polymorphisms) and acquired somatic copy number aberrations (CNAs) were associated with expression in ∼40% of genes, with the landscape dominated by cis- and trans-acting CNAs. By delineating expression outlier genes driven in cis by CNAs, we identified putative cancer genes, including deletions in PPP2R2A, MTAP and MAP2K4. Unsupervised analysis of paired DNA–RNA profiles revealed novel subgroups with distinct clinical outcomes, which reproduced in the validation cohort. These include a high-risk, oestrogen-receptor-positive 11q13/14 cis-acting subgroup and a favourable prognosis subgroup devoid of CNAs. Trans-acting aberration hotspots were found to modulate subgroup-specific gene networks, including a TCR deletion-mediated adaptive immune response in the ‘CNA-devoid’ subgroup and a basal-specific chromosome 5 deletion-associated mitotic network. Our results provide a novel molecular stratification of the breast cancer population, derived from the impact of somatic CNAs on the transcriptome.This publication has 29 references indexed in Scilit:
- Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast CancerJournal of Clinical Oncology, 2011
- High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2011
- ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epitheliumEMBO Molecular Medicine, 2011
- Subtype‐specific mutation of PPP2R1A in endometrial and ovarian carcinomasThe Journal of Pathology, 2011
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic SubtypesJournal of Clinical Oncology, 2009
- EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian CancerCell, 2003
- Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line.2002
- Diagnosis of multiple cancer types by shrunken centroids of gene expressionProceedings of the National Academy of Sciences of the United States of America, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001
- Molecular portraits of human breast tumoursNature, 2000